Market cap
₹3,032 Cr
Revenue (TTM)
₹742 Cr
P/E Ratio
27.7
P/B Ratio
9.2
Div. Yield
10.9 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹88 Cr
-
ROE
21 %
-
ROCE
31.9 %
-
Industry P/E
44.98
-
EV/EBITDA
17
-
Debt to Equity
0
-
Book Value
₹--
-
EPS
₹48.1
-
Face value
10
-
Shares outstanding
22,720,059
10 Years Aggregate
CFO
₹811.40 Cr
EBITDA
₹1,160.40 Cr
Net Profit
₹967.20 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Wyeth
| 68.8 | 17.4 | 32.6 | 63.8 | 12.5 | 11.7 | 10.0 |
|
BSE Sensex*
| -10.9 | -4.9 | -8.9 | -7.6 | 6.9 | 8.3 | 11.5 |
|
BSE Healthcare#
| 8.8 | 8.8 | 9.7 | 11.0 | 27.5 | 14.1 | 12.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Wyeth
|
1,333.9 | 3,032.2 | 741.6 | 109.4 | 18.9 | 36.4 | 27.7 | 9.2 |
| 2,951.2 | 24,140.1 | 1,339.4 | 356.4 | 33.2 | 23.2 | 67.8 | 14.6 | |
| 418.6 | 16,010.4 | 2,268.6 | 150.1 | 10.6 | 5.4 | 89.3 | 4.1 | |
| 752.0 | 18,624.4 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31.3 | 3.7 | |
| 1,006.4 | 16,019.7 | 8,279.6 | 397.8 | 9.9 | 6.4 | 40.2 | 2.3 | |
| 1,169.7 | 20,961.2 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 13.5 | 2.4 | |
| 1,834.5 | 21,027.8 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.6 | |
| 175.6 | 23,328.3 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.9 | |
| 461.9 | 18,639.4 | 3,738.7 | 316.7 | 12.5 | 7.5 | 58.9 | 3.9 | |
| 1,575.4 | 25,598.2 | 3,373.0 | 199.0 | 12.6 | 5.9 | 120.2 | 5.2 |
Shareholding Pattern
View DetailsNews & Analysis
All News
3 min read•By Research Desk
About Wyeth
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1947
-
Chairman
--
-
Managing Director
Aijaz Tobaccowalla
-
Group
Wyeth - MNC
-
Headquarters
Mumbai, Maharashtra
-
Website
Annual Reports
Announcements
View AnnouncementsFixes Record Date for Amalgamation
02-Dec-2014Effective Date of Scheme of Amalgamation
01-Dec-2014Disclosure of Voting results of AGM (Clause 35A)
12-Nov-2014Shareholding Pattern For September 30, 2014
16-Oct-2014No News & Announcements are available.
FAQs for Wyeth
What is the current share price of Wyeth Ltd Today?
The share price of Wyeth Ltd is ₹1,333.85 (NSE) and ₹1,334.60 (BSE) as of 09-Dec-2014 IST. Wyeth Ltd has given a return of 12.53% in the last 3 years.
What is the current PB & PE ratio of Wyeth Ltd?
The P/E ratio of Wyeth Ltd is 27.72 times as on 09-Dec-2014, a 38 discount to its peers’ median range of 44.98 times.
The P/B ratio of Wyeth Ltd is 9.15 times as on 09-Dec-2014, a 138 premium to its peers’ median range of 3.85 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2014
|
23.01
|
7.51
|
|
2013
|
15.88
|
3.64
|
|
2012
|
13.63
|
4.09
|
|
2009
|
9.51
|
3.49
|
|
2008
|
12.68
|
4.00
|
What is the 52 Week High and Low of Wyeth Ltd?
The 52-week high and low of Wyeth Ltd are Rs -- and Rs -- as of 24-May-2026.
What is the market cap of Wyeth Ltd?
Wyeth Ltd has a market capitalisation of ₹ 3,032 Cr as on 09-Dec-2014. As per SEBI classification, it is a company.
Should I invest in Wyeth Ltd?
Before investing in Wyeth Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.